First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Kura Oncology, Inc.
Kura Oncology, Inc.
Dren Bio
Incyte Corporation
Quetzal Therapeutics
AVM Biotechnology Inc
Orca Biosystems, Inc.
Kura Oncology, Inc.
Kura Oncology, Inc.
Taiho Oncology, Inc.
AvenCell Therapeutics, Inc.
Daiichi Sankyo
Vironexis Biotherapeutics Inc.
Pfizer
Syndax Pharmaceuticals
Kura Oncology, Inc.
Ossium Health, Inc.
Adela, Inc
AstraZeneca
AbbVie
First Ascent Biomedical Inc.
AbbVie
Daiichi Sankyo
Nerviano Medical Sciences
Massive Bio, Inc.
Molecular Partners AG
BlossomHill Therapeutics
Cogent Biosciences, Inc.
Hikma Pharmaceuticals LLC
Munich Leukemia Laboratory
Munich Leukemia Laboratory
Vincerx Pharma, Inc.
Kyowa Kirin Co., Ltd.
Sanguine Biosciences
Chongqing Precision Biotech Co., Ltd